相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dynamic contrast-enhanced computed tomography for the quantification of tumor response to vasoactive agents in a rat tumor model: preliminary results
Rachel E. Pollard et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2011)
On the Scope and Interpretation of the Tofts Models for DCE-MRI
Steven P. Sourbron et al.
MAGNETIC RESONANCE IN MEDICINE (2011)
Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies
Erica L. Mayer et al.
CLINICAL CANCER RESEARCH (2010)
Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
Elaine T. Lam et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Assessment of Acute Antivascular Effects of Vandetanib with High- Resolution Dynamic Contrast-Enhanced Computed Tomographic Imaging in a Human Colon Tumor Xenograft Model in the Nude Rat
Joo Ho Tai et al.
NEOPLASIA (2010)
Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer
Giulia Bianchi et al.
ANTI-CANCER DRUGS (2009)
Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer
Jeanny B. Aragon-Ching et al.
BJU INTERNATIONAL (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
In Vivo Monitoring of Angiogenesis Inhibitory Treatment Effects by Dynamic Contrast-Enhanced Computed Tomography in a Xenograft Tumor Model
Hans-Juergen Raatschen et al.
INVESTIGATIVE RADIOLOGY (2009)
Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non-Small-Cell Lung Cancer
Simon J. Crabb et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Benign Prostatic Hyperplasia: Evaluation of T1, T2, and Microvascular Characteristics With T1-Weighted Dynamic Contrast-Enhanced MRI
Lucy E. Kershaw et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2009)
Quantification of Cerebral Blood Flow, Cerebral Blood Volume, and Blood-Brain-Barrier Leakage with DCE-MRI
Steven Sourbron et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
Sorafenib Triggers Antiproliferative and Pro-Apoptotic Signals in Human Esophageal Adenocarcinoma Cells
Jorge-Shmuel Delgado et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Experimental therapy for advanced renal cell carcinoma
Thomas E. Hutson et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
MRI-measurement of perfusion and glomerular filtration in the human kidney with a separable compartment model
Steven P. Sourbron et al.
INVESTIGATIVE RADIOLOGY (2008)
New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues
Clemens C. Cyran et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)
Multimodality molecular imaging of tumor angiogenesis
Weibo Cai et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer
K. N. Chi et al.
ANNALS OF ONCOLOGY (2008)
CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: Initial experience
Massimo Bellomi et al.
RADIOLOGY (2007)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
Yong S. Chang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Pixel-by-pixel deconvolution of bolus-tracking data: optimization and implementation
S. Sourbron et al.
PHYSICS IN MEDICINE AND BIOLOGY (2007)
Molecular therapy in urologic oncology
Michael Froehner et al.
UROLOGIA INTERNATIONALIS (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
Raf kinases: Oncogenesis and drug discovery
Ralf Schreck et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Precision in measurements of perfusion and microvascular permeability with T1-weighted dynamic contrast-enhanced MRI
Lucy E. Kershaw et al.
MAGNETIC RESONANCE IN MEDICINE (2006)
Feasibility and measurement precision of 3D quantitative blood flow mapping of the prostate using dynamic contrast-enhanced multi-slice CT
Cecile R. L. P. N. Jeukens et al.
PHYSICS IN MEDICINE AND BIOLOGY (2006)
Magnetic resonance characterization of tumor microvessels in experimental breast tumors using a slow clearance blood pool contrast agent (carboxymethyldextran-A2-Gd-DOTA) with histopathological correlation
A Preda et al.
EUROPEAN RADIOLOGY (2005)
Raf: A strategic target for therapeutic development against cancer
M Beeram et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
Prostate cancer: Evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging - Initial experience
DL Buckley et al.
RADIOLOGY (2004)
Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy
R Hermans et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Functional CT imaging of prostate cancer
E Henderson et al.
PHYSICS IN MEDICINE AND BIOLOGY (2003)
Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma
U Tateishi et al.
CANCER (2002)
Application of CT in the investigation of angiogenesis in oncology
KA Miles et al.
ACADEMIC RADIOLOGY (2000)
Body CT and oncologic imaging
KD Hopper et al.
RADIOLOGY (2000)
分享论文
